Global Infectious Disease Therapeutics Market Research Report 2023

Report ID: 1974677 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Infectious Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drugs
        1.2.3 Vaccines
    1.3 Market by Application
        1.3.1 Global Infectious Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 HIV/AIDS
        1.3.3 Influenza
        1.3.4 Hepatitis
        1.3.5 Malaria
        1.3.6 Tuberculosis
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Infectious Disease Therapeutics Market Perspective (2017-2028)
    2.2 Infectious Disease Therapeutics Growth Trends by Region
        2.2.1 Infectious Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Infectious Disease Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Infectious Disease Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Infectious Disease Therapeutics Market Dynamics
        2.3.1 Infectious Disease Therapeutics Industry Trends
        2.3.2 Infectious Disease Therapeutics Market Drivers
        2.3.3 Infectious Disease Therapeutics Market Challenges
        2.3.4 Infectious Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Infectious Disease Therapeutics Players by Revenue
        3.1.1 Global Top Infectious Disease Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Infectious Disease Therapeutics Revenue
    3.4 Global Infectious Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Therapeutics Revenue in 2021
    3.5 Infectious Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Infectious Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Infectious Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Therapeutics Breakdown Data by Type
    4.1 Global Infectious Disease Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Infectious Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Infectious Disease Therapeutics Breakdown Data by Application
    5.1 Global Infectious Disease Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Infectious Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Infectious Disease Therapeutics Market Size (2017-2028)
    6.2 North America Infectious Disease Therapeutics Market Size by Country (2017-2022)
    6.3 North America Infectious Disease Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Infectious Disease Therapeutics Market Size (2017-2028)
    7.2 Europe Infectious Disease Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Infectious Disease Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Infectious Disease Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Infectious Disease Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Infectious Disease Therapeutics Market Size (2017-2028)
    9.2 Latin America Infectious Disease Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Infectious Disease Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Infectious Disease Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis AG
        11.1.1 Novartis AG Company Detail
        11.1.2 Novartis AG Business Overview
        11.1.3 Novartis AG Infectious Disease Therapeutics Introduction
        11.1.4 Novartis AG Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.1.5 Novartis AG Recent Development
    11.2 Gilead
        11.2.1 Gilead Company Detail
        11.2.2 Gilead Business Overview
        11.2.3 Gilead Infectious Disease Therapeutics Introduction
        11.2.4 Gilead Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.2.5 Gilead Recent Development
    11.3 GlaxoSmithKline plc
        11.3.1 GlaxoSmithKline plc Company Detail
        11.3.2 GlaxoSmithKline plc Business Overview
        11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Introduction
        11.3.4 GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.3.5 GlaxoSmithKline plc Recent Development
    11.4 Janssen Pharmaceutical Inc.
        11.4.1 Janssen Pharmaceutical Inc. Company Detail
        11.4.2 Janssen Pharmaceutical Inc. Business Overview
        11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Introduction
        11.4.4 Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.4.5 Janssen Pharmaceutical Inc. Recent Development
    11.5 F. Hoffmann-La Roche Ltd.
        11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
        11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
        11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Introduction
        11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
    11.6 BioCryst Pharmaceuticals Inc.
        11.6.1 BioCryst Pharmaceuticals Inc. Company Detail
        11.6.2 BioCryst Pharmaceuticals Inc. Business Overview
        11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Introduction
        11.6.4 BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.6.5 BioCryst Pharmaceuticals Inc. Recent Development
    11.7 Merck & Co. Inc.
        11.7.1 Merck & Co. Inc. Company Detail
        11.7.2 Merck & Co. Inc. Business Overview
        11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Introduction
        11.7.4 Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.7.5 Merck & Co. Inc. Recent Development
    11.8 Boehringer Ingelheim GmbH
        11.8.1 Boehringer Ingelheim GmbH Company Detail
        11.8.2 Boehringer Ingelheim GmbH Business Overview
        11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Introduction
        11.8.4 Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2017-2022)
        11.8.5 Boehringer Ingelheim GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Infectious Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Drugs
    Table 3. Key Players of Vaccines
    Table 4. Global Infectious Disease Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Infectious Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Infectious Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Infectious Disease Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Infectious Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Infectious Disease Therapeutics Market Share by Region (2023-2028)
    Table 10. Infectious Disease Therapeutics Market Trends
    Table 11. Infectious Disease Therapeutics Market Drivers
    Table 12. Infectious Disease Therapeutics Market Challenges
    Table 13. Infectious Disease Therapeutics Market Restraints
    Table 14. Global Infectious Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Infectious Disease Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Therapeutics as of 2021)
    Table 17. Ranking of Global Top Infectious Disease Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Infectious Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Infectious Disease Therapeutics Product Solution and Service
    Table 21. Date of Enter into Infectious Disease Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Infectious Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Infectious Disease Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Infectious Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Infectious Disease Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Infectious Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Infectious Disease Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Infectious Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Infectious Disease Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Novartis AG Company Detail
    Table 42. Novartis AG Business Overview
    Table 43. Novartis AG Infectious Disease Therapeutics Product
    Table 44. Novartis AG Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. Novartis AG Recent Development
    Table 46. Gilead Company Detail
    Table 47. Gilead Business Overview
    Table 48. Gilead Infectious Disease Therapeutics Product
    Table 49. Gilead Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Gilead Recent Development
    Table 51. GlaxoSmithKline plc Company Detail
    Table 52. GlaxoSmithKline plc Business Overview
    Table 53. GlaxoSmithKline plc Infectious Disease Therapeutics Product
    Table 54. GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. GlaxoSmithKline plc Recent Development
    Table 56. Janssen Pharmaceutical Inc. Company Detail
    Table 57. Janssen Pharmaceutical Inc. Business Overview
    Table 58. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product
    Table 59. Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Janssen Pharmaceutical Inc. Recent Development
    Table 61. F. Hoffmann-La Roche Ltd. Company Detail
    Table 62. F. Hoffmann-La Roche Ltd. Business Overview
    Table 63. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product
    Table 64. F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. F. Hoffmann-La Roche Ltd. Recent Development
    Table 66. BioCryst Pharmaceuticals Inc. Company Detail
    Table 67. BioCryst Pharmaceuticals Inc. Business Overview
    Table 68. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product
    Table 69. BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. BioCryst Pharmaceuticals Inc. Recent Development
    Table 71. Merck & Co. Inc. Company Detail
    Table 72. Merck & Co. Inc. Business Overview
    Table 73. Merck & Co. Inc. Infectious Disease Therapeutics Product
    Table 74. Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Merck & Co. Inc. Recent Development
    Table 76. Boehringer Ingelheim GmbH Company Detail
    Table 77. Boehringer Ingelheim GmbH Business Overview
    Table 78. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product
    Table 79. Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Boehringer Ingelheim GmbH Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Drugs Features
    Figure 3. Vaccines Features
    Figure 4. Global Infectious Disease Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. HIV/AIDS Case Studies
    Figure 6. Influenza Case Studies
    Figure 7. Hepatitis Case Studies
    Figure 8. Malaria Case Studies
    Figure 9. Tuberculosis Case Studies
    Figure 10. Others Case Studies
    Figure 11. Infectious Disease Therapeutics Report Years Considered
    Figure 12. Global Infectious Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Infectious Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Infectious Disease Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Infectious Disease Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Infectious Disease Therapeutics Revenue in 2021
    Figure 18. North America Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Infectious Disease Therapeutics Market Share by Country (2017-2028)
    Figure 20. United States Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Infectious Disease Therapeutics Market Share by Country (2017-2028)
    Figure 24. Germany Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Infectious Disease Therapeutics Market Share by Region (2017-2028)
    Figure 32. China Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Infectious Disease Therapeutics Market Share by Country (2017-2028)
    Figure 40. Mexico Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Infectious Disease Therapeutics Market Share by Country (2017-2028)
    Figure 44. Turkey Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Novartis AG Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 47. Gilead Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 48. GlaxoSmithKline plc Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 49. Janssen Pharmaceutical Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 51. BioCryst Pharmaceuticals Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 52. Merck & Co. Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 53. Boehringer Ingelheim GmbH Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH
Frequently Asked Questions
Infectious Disease Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Infectious Disease Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Infectious Disease Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Infectious Vaccines

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Ingestible Sensors

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Inhalable Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More